HORIZONH2020
European Liver Patients Association
- Country
- BEBelgium
- Defence projects
- 0
- Projects, all programmes
- 13
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 1,228,466
- Active
- 2017 to 2025
Projects
13 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| VIROMARKERSVirus related biomarkers to improve management of chronic conditions | HORIZON | 2025 | Participant | EUR 50,000 |
| ARTEMISAcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients | HORIZON | 2024 | Participant | EUR 199,000 |
| LEOPARDLiver Electronic Offering Platform with Artificial intelligence-based Devices | HORIZON | 2023 | Participant | EUR 83,125 |
| GENIALUnderstanding Gene ENvironment Interaction in ALcohol-related hepatocellular carcinoma | HORIZON | 2023 | Participant | EUR 83,375 |
| THRIVETUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS | HORIZON | 2023 | Participant | EUR 169,250 |
| LIVERATIONUnravelling the impact of Radiofrequency in liver surgery: the key to decrease local recurrence? | HORIZON | 2023 | Participant | EUR 127,500 |
| GRIPonMASHGRIP on MASH: Global Research Initiative for Patient Screening on MASH | HORIZON | 2023 | Participant | EUR 30,000 |
| A-TANGONOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242 | H2020 | 2021 | Participant | EUR 44,300 |
| DECISIONDECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES | H2020 | 2020 | Participant | EUR 37,500 |
| LiverScreenScreening for liver fibrosis - population-based study across European countries | H2020 | 2020 | Participant | EUR 49,416 |
| IP-cure-BImmune profiling to guide host-directed interventions to cure HBV infections | H2020 | 2020 | Participant | EUR 175,000 |
| MICROB-PREDICTMICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response | H2020 | 2019 | Participant | EUR 80,000 |
| LIVERHOPESIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS | H2020 | 2017 | Participant | EUR 100,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.